Submission Details
| 510(k) Number | K190463 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 26, 2019 |
| Decision Date | April 19, 2019 |
| Days to Decision | 52 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
K190463 is an FDA 510(k) clearance for the Cepheid Xpert C. difficile/Epi Control Panel, a Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays (Class II — Special Controls, product code PMN), submitted by Microbiologics, Inc. (St. Cloud, US). The FDA issued a Cleared decision on April 19, 2019, 52 days after receiving the submission on February 26, 2019. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3920.
| 510(k) Number | K190463 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 26, 2019 |
| Decision Date | April 19, 2019 |
| Days to Decision | 52 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | Summary PDF |
| Product Code | PMN — Assayed External Control Material For Microbiology Nucleic Acid Amplification (nat) Assays |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 866.3920 |
| Definition | Assayed External Quality Control Material To Monitor The Performance Of Microbiology Nucleic Acid Assays For In Vitro Diagnostic Use. |